🇺🇸 FDA
Pipeline program

Adolescent Methamphetamine Treament (AMT)

DA021695

Phase 1 other completed

Quick answer

Adolescent Methamphetamine Treament (AMT) for Behavior and Mental Disorders is a Phase 1 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Behavior and Mental Disorders
Phase
Phase 1
Modality
other
Status
completed

Clinical trials